Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aegis Therapeutics LLC

www.aegisthera.com

Latest From Aegis Therapeutics LLC

Keeping Track: FDA Approves First Generic Advair, But Alkermes And Sunovion Land CRLs

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Hazards Ahead For New Drugs At US FDA Amid Safety Concerns, Shutdown Disruption

The pipeline for new drug candidates remains healthy as 2019 begins, with almost 40 novel agents already under FDA review. But the chances of another record-breaking year are threatened by a confluence of safety issues that are putting risk management back in the spotlight – and by the widening ripple effects of the recent US government shutdown.

Drug Review Approvals

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  
Drug Review Biosimilars

Keeping Track: Three Oncologics, A New Migraine Preventive, And First LPAD Antibiotic Clear US FDA

The latest drug development news and highlights from our FDA Performance Tracker.  
Drug Review Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Nasal
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Aegis Therapeutics Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aegis Therapeutics LLC
  • Senior Management
  • Edward T Maggio, PhD, CEO
    Ralph R Barry, CBO
  • Contact Info
  • Aegis Therapeutics LLC
    Phone: (858) 618-1400
    11770 Bernardo Plaza Ct.
    Ste. 353
    San Diego, CA 92128
    USA
UsernamePublicRestriction

Register